Bachem regains the upswing – significantly improved Business Performance in second semester

  • Leading market position maintained and strenghened – Quality Matters!
  • Sales growth of 12% in second semester compared to first half of 2010 (at comparable exchange rates)
  • Full year EBIT more than tripled versus first semester of 2010 (before special items and at comparable exchange rates)
  • Pipeline expanded thanks to the successful acquisition of new projects
  • Sustainable annual cost savings of 5.8 million CHF achieved
  • Reorganization in North America completed; non-GMP custom synthesis now handled by Bachem competence center in the UK
  • Attractive dividend of CHF 2.50 proposed